<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2678308-A1" country="EP" doc-number="2678308" kind="A1" date="20140101" family-id="46025964" file-reference-id="318304" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146551187" ucid="EP-2678308-A1"><document-id><country>EP</country><doc-number>2678308</doc-number><kind>A1</kind><date>20140101</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12718534-A" is-representative="NO"><document-id mxw-id="PAPP154825110" load-source="docdb" format="epo"><country>EP</country><doc-number>12718534</doc-number><kind>A</kind><date>20120420</date><lang>EN</lang></document-id><document-id mxw-id="PAPP180246559" load-source="docdb" format="original"><country>EP</country><doc-number>12718534.6</doc-number><date>20120420</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140452828" ucid="US-201161477851-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>201161477851</doc-number><kind>P</kind><date>20110421</date></document-id></priority-claim><priority-claim mxw-id="PPC140447475" ucid="US-2012034441-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>2012034441</doc-number><kind>W</kind><date>20120420</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1988121728" load-source="docdb">A61Q  19/10        20060101ALI20121109BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988123135" load-source="docdb">A61K   8/41        20060101ALI20121109BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988127731" load-source="docdb">A61Q  19/00        20060101ALI20121109BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1988132342" load-source="docdb">C07C 217/08        20060101AFI20121109BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2034533264" load-source="docdb" scheme="CPC">A61K2800/10        20130101 LA20150728BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2034536527" load-source="docdb" scheme="CPC">C07C 217/08        20130101 LI20150728BHEP        </classification-cpc><classification-cpc mxw-id="PCL-2034538085" load-source="docdb" scheme="CPC">A61Q   5/00        20130101 LI20150728BHEP        </classification-cpc><classification-cpc mxw-id="PCL2007295793" load-source="docdb" scheme="CPC">A61Q   5/12        20130101 LI20140123BHEP        </classification-cpc><classification-cpc mxw-id="PCL2007295794" load-source="docdb" scheme="CPC">A61Q  19/00        20130101 LI20140201BHEP        </classification-cpc><classification-cpc mxw-id="PCL2007295795" load-source="docdb" scheme="CPC">A61K   8/416       20130101 FI20140201BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132186045" lang="DE" load-source="patent-office">ETHER MIT MONOKATIONISCHER POLYHYDROXYLFUNKTIONALITÄT</invention-title><invention-title mxw-id="PT132186046" lang="EN" load-source="patent-office">ETHERS WITH MONOCATIONIC POLYHYDROXYL FUNCTIONALITY</invention-title><invention-title mxw-id="PT132186047" lang="FR" load-source="patent-office">ÉTHERS PRÉSENTANT UNE FONCTIONNALITÉ POLYHYDROXYLE MONOCATIONIQUE</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR918153643" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>DOW GLOBAL TECHNOLOGIES LLC</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR918139227" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DOW GLOBAL TECHNOLOGIES LLC</last-name></addressbook></applicant><applicant mxw-id="PPAR918979651" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Dow Global Technologies LLC</last-name><iid>101225780</iid><address><street>2040 Dow Center</street><city>Midland, MI 48674</city><country>US</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR918143022" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>DEAVENPORT JOSEPH L</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918163924" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>DEAVENPORT, JOSEPH L.</last-name></addressbook></inventor><inventor mxw-id="PPAR918991304" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>DEAVENPORT, JOSEPH L.</last-name><address><street>106 Post Oak</street><city>Lake Jackson, TX 77566</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918170777" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>BREHM NICOLE A</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR918136051" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>BREHM, NICOLE A.</last-name></addressbook></inventor><inventor mxw-id="PPAR918990002" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>BREHM, NICOLE A.</last-name><address><street>306 Crocus Street</street><city>Lake Jackson, TX 77566</city><country>US</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR918984694" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Buckley, Guy Julian</last-name><iid>100026757</iid><address><street>Patent Outsourcing Limited 1 King Street</street><city>Bakewell Derbyshire DE45 1DZ</city><country>GB</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="US-2012034441-W"><document-id><country>US</country><doc-number>2012034441</doc-number><kind>W</kind><date>20120420</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012145621-A1"><document-id><country>WO</country><doc-number>2012145621</doc-number><kind>A1</kind><date>20121026</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS548864830" load-source="docdb">AL</country><country mxw-id="DS548836683" load-source="docdb">AT</country><country mxw-id="DS548864831" load-source="docdb">BE</country><country mxw-id="DS548912287" load-source="docdb">BG</country><country mxw-id="DS548925266" load-source="docdb">CH</country><country mxw-id="DS548925923" load-source="docdb">CY</country><country mxw-id="DS548836684" load-source="docdb">CZ</country><country mxw-id="DS548864832" load-source="docdb">DE</country><country mxw-id="DS548925924" load-source="docdb">DK</country><country mxw-id="DS548925925" load-source="docdb">EE</country><country mxw-id="DS548933799" load-source="docdb">ES</country><country mxw-id="DS548912288" load-source="docdb">FI</country><country mxw-id="DS548912289" load-source="docdb">FR</country><country mxw-id="DS548864833" load-source="docdb">GB</country><country mxw-id="DS548925926" load-source="docdb">GR</country><country mxw-id="DS548864834" load-source="docdb">HR</country><country mxw-id="DS548836685" load-source="docdb">HU</country><country mxw-id="DS548925267" load-source="docdb">IE</country><country mxw-id="DS548925927" load-source="docdb">IS</country><country mxw-id="DS548912290" load-source="docdb">IT</country><country mxw-id="DS548925928" load-source="docdb">LI</country><country mxw-id="DS548815511" load-source="docdb">LT</country><country mxw-id="DS548836686" load-source="docdb">LU</country><country mxw-id="DS548815512" load-source="docdb">LV</country><country mxw-id="DS548815513" load-source="docdb">MC</country><country mxw-id="DS548928036" load-source="docdb">MK</country><country mxw-id="DS548928037" load-source="docdb">MT</country><country mxw-id="DS548836687" load-source="docdb">NL</country><country mxw-id="DS548933800" load-source="docdb">NO</country><country mxw-id="DS548925268" load-source="docdb">PL</country><country mxw-id="DS548815514" load-source="docdb">PT</country><country mxw-id="DS548836688" load-source="docdb">RO</country><country mxw-id="DS548815515" load-source="docdb">RS</country><country mxw-id="DS548925269" load-source="docdb">SE</country><country mxw-id="DS548912291" load-source="docdb">SI</country><country mxw-id="DS548933801" load-source="docdb">SK</country><country mxw-id="DS548925270" load-source="docdb">SM</country><country mxw-id="DS548928162" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><abstract mxw-id="PA101341394" ref-ucid="WO-2012145621-A1" lang="EN" load-source="patent-office"><p num="0000">Described are novel monocationic polyhydroxyl compounds and their uses in personal care compositions.</p></abstract><abstract mxw-id="PA101772370" ref-ucid="WO-2012145621-A1" lang="EN" source="national office" load-source="docdb"><p>Described are novel monocationic polyhydroxyl compounds and their uses in personal care compositions.</p></abstract><abstract mxw-id="PA101341395" ref-ucid="WO-2012145621-A1" lang="FR" load-source="patent-office"><p num="0000">L'invention concerne de nouveaux composés polyhydroxylés monocationiques et leurs utilisations dans des compositions de soins personnels.</p></abstract><abstract mxw-id="PA101772371" ref-ucid="WO-2012145621-A1" lang="FR" source="national office" load-source="docdb"><p>L'invention concerne de nouveaux composés polyhydroxylés monocationiques et leurs utilisations dans des compositions de soins personnels.</p></abstract><description mxw-id="PDES52190084" ref-ucid="WO-2012145621-A1" lang="EN" load-source="patent-office"><!-- EPO <DP n="2"/>--><p id="p0001" num="0001"> ETHERS WITH MONOCATIONIC </p><p id="p0002" num="0002"> POLYHYDROXYL FUNCTIONALITY </p><p id="p0003" num="0003"> Field </p><p id="p0004" num="0004"> The present invention relates to novel monocationic polyhydroxyl compounds and their uses in personal care compositions. </p><p id="p0005" num="0005">Background </p><p id="p0006" num="0006"> Polyhydroxyl compounds, or polyols, have a number of uses, from raw materials used in the manufacture of urethane foams to humectants for personal care products like shaving foams, lotions, and shampoos. </p><p id="p0007" num="0007"> Quaternary ammonium compounds are also useful in a number of applications, such as for disinfectants, surfactants, fabric softeners, and conditioners in shampoos. </p><p id="p0008" num="0008"> Despite the number of available conventional compounds, there is a strong need for novel compounds with properties to differentiate performance or offer synergistic effects in areas of interest, particularly in personal care compositions. </p><p id="p0009" num="0009">Detailed Description </p><p id="p0010" num="0010"> In one embodiment, the present invention provides compounds, including salts, of the Formula (I): </p><p id="p0011" num="0011"><img id="imgf000002_0001" he="41" wi="133" file="imgf000002_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0012" num="0012"> (I) 
<!-- EPO <DP n="3"/>-->
 wherein: </p><p id="p0013" num="0013"> wherein: </p><p id="p0014" num="0014"> m is 1, 2, 3, 4, 5, or 6; </p><p id="p0015" num="0015"> Ria, Rib, R<sub>2a</sub>, R<sub>2</sub>b, Rta, and R<sub>4</sub> , are, independently at each occurrence, H, optionally substituted C1-C6 alkyl; and </p><p id="p0016" num="0016"> R3a, R3b and R5 are, independently, optionally substituted C1-C6 alkyl. </p><p id="p0017" num="0017"> The term "optionally substituted" as used herein means that the groups in question are either unsubstituted or substituted with one or more groups, radicals or moieties, selected from halogen, hydroxy, amino or carboxy. When the groups in question are substituted with more than one substituent, the substituents may be the same or different. In one embodiment, the optional substituent is selected to produce a cosmetically acceptable compound. </p><p id="p0018" num="0018">"Cosmetically acceptable" refers to ingredients typically used in personal care compositions, and is intended to underscore that materials that are toxic, irritating, or unpleasant smelling when present in the amounts typically found in personal care compositions are not contemplated as part of the present invention. In one embodiment, the optional substituent is hydroxy. </p><p id="p0019" num="0019"> "Alkyl" means a saturated monovalent linear or branched aliphatic hydrocarbon radical. Representative examples include, but are not limited to methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, sec-butyl, pentyl, isopentyl, neopentyl, hexyl, isohexyl, and the like. </p><p id="p0020" num="0020"> The term "cycloalkyl" denotes a saturated monocyclic or bicyclic cycloalkyl group. Examples of cycloalkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, and the like. In one embodiment, the cycloalkyl is cyclohexyl or cyclopentyl. </p><p id="p0021" num="0021"> Salts means that a counter-ion is present, preferably halogen, more preferably CI<sup>"</sup>. 
<!-- EPO <DP n="4"/>-->
 In one embodiment, m is 2, 3, or 4. Preferably, m is 2. </p><p id="p0022" num="0022"> In some embodiments, Rj<sub>a</sub> and R<sub>¾</sub> are H at each occurrence. In some embodiments, at least one P^<sub>a</sub> is -CH<sub>3</sub>, -CH2OH, or -CH2CH<sub>3</sub>. Alternatively, Rj<sub>a</sub> and R<sub>¾</sub> may cooperate, along with the carbon to which they are attached, to form a cycloalkyl group. </p><p id="p0023" num="0023"> In a preferred embodiment, R5 is -CH2CH2OH. </p><p id="p0024" num="0024"> In one embodiment, R]<sub>a</sub> and are each H. </p><p id="p0025" num="0025"> In one embodiment, R<sub>2a</sub> and R<sub>2b</sub> are each H. </p><p id="p0026" num="0026"> In some embodiments, R<sub>3a</sub> and R<sub>¾</sub> are the same. Examples of such embodiments include those where R<sub>3a</sub> and R<sub>¾</sub> are each -CH<sub>3</sub>, those where R<sub>3a</sub> and R<sub>¾</sub> are each -CH2CH<sub>3</sub>, and those where R<sub>3a</sub> and R<sub>¾</sub> are each -CH2CH2OH. </p><p id="p0027" num="0027"> Alternatively, in some embodiments, R<sub>3a</sub> and R<sub>¾</sub> are not the same. Examples of such embodiments include those where R<sub>3a</sub> is -CH2CH2OH. In one embodiment, R<sub>3a</sub> is </p><p id="p0028" num="0028">-CH2CH2OH and R<sub>3b</sub> is -(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>. </p><p id="p0029" num="0029"> Non-limiting examples of compounds of Formula I include the reaction products of 3- chloro-l,2-propanediol and amino ether alcohols. Non- limiting examples of these include 2- (2-dimethylamino)ethoxyethanol, 2-[2-(diethylamino)ethoxy]ethanol, 2-[2-(dimethylamino)- l-methylethoxy]ethanol, and Ethyl(2-hydroxyethyl)[2-(2-hydroxyethoxy)ethyl] amine. </p><p id="p0030" num="0030"> In one embodiment, the present invention provides methods for providing </p><p id="p0031" num="0031">humectancy in a personal care composition, comprising including the compound of Formula I into the personal care composition. The ingredients used, and their proportions and manner of addition, are familiar to those versed in conventional personal care compositions, including, optionally, cosmetically acceptable emollients, moisturizers, conditioners, oils, sunscreens, surfactants, emulsifiers, preservatives, rheology modifiers, colorants, preservatives, pH adjustors, propellants, reducing agents, fragrances, foaming or de-foaming agents, tanning agents, depilatory agents, astringents, antiseptics, deodorants, antiperspirants, insect repellants, bleaches, lighteners, anti-dandruff agents, adhesives, polishes, 
<!-- EPO <DP n="5"/>-->
 strengtheners, fillers, barrier materials, or biocides. </p><p id="p0032" num="0032"> In one embodiment, the present invention provides hair care compositions containing the compound of Formula I. </p><p id="p0033" num="0033"> In one embodiment, the present invention provides skin care compositions containing the compound of Formula I. </p><p id="p0034" num="0034">Examples </p><p id="p0035" num="0035"> The following examples are for illustrative purposes only and are not intended to limit the scope of the present invention. </p><p id="p0036" num="0036">Example 1 </p><p id="p0037" num="0037"> Reaction of 3-chloro-l,2-propanediol and 2-[2-(dimethylamino)ethoxy]ethanol to afford 2,3- dihydroxy-N-(2-(2-hydroxyethoxy )ethyl)-N,N-dimethylpropan-l -aminium chloride </p><p id="p0038" num="0038"> H </p><p id="p0039" num="0039"><img id="imgf000005_0001" he="35" wi="85" file="imgf000005_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0040" num="0040"> A 250 mL round bottom, jacketed, flask was equipped with a magnetic stir bar and placed on a stir-plate. The temperature was set to about 25 °C and monitored with a thermocouple. 48.84 g 2-(2-dimethylamino)ethoxyethanol (98% purity, 0.36 mole) was combined with 49.05 g deionized water and allowed to mix for about fifteen minutes before commencing the addition of 40.32 g 3-chloro-l,2-dihydroxypropane (99.6% purity, 0.36mole) over lhour at 25 °C. The reaction solution was allowed to stir for about 1 hour at 25 °C and then for about 4 hours at 45 °C (hot digest). After the hot digest step was 
<!-- EPO <DP n="6"/>-->
 completed, the circulation bath was turned off and solution was allowed to cool. At this time, the pH was adjusted to 7.1 with 0.02 moles of HC1. </p><p id="p0041" num="0041"><sup>13</sup>C NMR spectra acquired from a Bruker 300MHz spectrometer (samples prepared as -30 wt in D<sub>2</sub>0) confirmed the title compound: DEPT NMR (250 MHz, D<sub>2</sub>0) 54.9, 62.7, 66.1, 66.5, 66.7, 68.5, 69.3, 74.1 </p><p id="p0042" num="0042">Example 2 </p><p id="p0043" num="0043"> Reaction of 3-chloro-l,2-propanediol and 2-[2-(diethylamino)ethoxy]ethanol to afford N,N- diethyl-2, 3-dihydroxy-N-(2-(2-hydroxyethoxy )ethyl)propan-l -aminium chloride </p><p id="p0044" num="0044"> H </p><p id="p0045" num="0045"><img id="imgf000006_0001" he="43" wi="84" file="imgf000006_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/></p><p id="p0046" num="0046"> The title compound is prepared substantially according to the protocol of Example 1, except that the conditions and amounts of reactants may vary, typically a 1 : 1 mol ratio with a slight excess of 3-chloro-l,2-propanediol, but which factors are well within the skill of one ordinarily skilled in the art. </p><p id="p0047" num="0047">Example 3 </p><p id="p0048" num="0048"> Reaction of 3-chloro-l,2-propanediol and Ethyl(2-hydroxyethyl)[2-(2- hydroxyethoxy)ethyl] amine to afford N-ethyl-2, 3-dihydroxy-N-(2-(2-hydroxyethoxy )ethyl)-N- (2-hydroxyethyl)propan-l -aminium chloride 
<!-- EPO <DP n="7"/>-->

<img id="imgf000007_0001" he="37" wi="89" file="imgf000007_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 </p><p id="p0049" num="0049"> The title compound is prepared substantially according to the protocol of Example 1 , except that the conditions and amounts of reactants may vary, typically a 1:1 mol ratio with a slight excess of 3-chloro-l,2-propanediol, but which factors are well within the skill of one ordinarily skilled in the art. </p><p id="p0050" num="0050">Example 4 </p><p id="p0051" num="0051"> Reaction of 3-chloro-l,2-propanediol and 2-[2-(dimethylamino)-l-methylethoxy]ethanol to afford 2, 3-dihydroxy-N-(2-(2-hydroxyethoxy )propyl)-N,N-dimethylpropan-l -aminium chloride 
<img id="imgf000007_0002" he="19" wi="95" file="imgf000007_0002.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/>
 </p><p id="p0052" num="0052"> The title compound is prepared substantially according to the protocol of Example 1, except that the conditions and amounts of reactants may vary, typically a 1 : 1 mol ratio with a slight excess of 3-chloro-l,2-propanediol, but which factors are well within the skill of one ordinarily skilled in the art. </p><p id="p0053" num="0053">Example 5 </p><p id="p0054" num="0054"> Compounds prepared substantially according to the Examples 1-4 are made and formulated into personal care compositions having otherwise conventional ingredients. The compositions are evaluated by trained panelists, with each panelist being asked to compare 
<!-- EPO <DP n="8"/>-->
 the inventive compositions to a conventional composition. </p><p id="p0055" num="0055"> For hair care compositions, wet and dry feel preference and wet and dry combability is measured by asking the panelists to feel and comb two hair tresses of European virgin brown hair, commercially available from International Hair Importers and Products Inc. NY (USA), one hair tress treated with an inventive composition, the other hair tress treated with a conventional composition. Each panelist is asked to compare the tresses and state which tress is smoother to comb / feel. The answer "same" is not allowed. The reported number is the percent of panelists preferring one over the other. </p><p id="p0056" num="0056"> For skin care compositions, panelists apply a sample (one inventive composition, one conventional composition) to a designated area on their right or left forearm. Initially, each sample is evaluated for ease of application, play time, evenness of deposit, coverage, speed of adsorbtion, shine, matte, skin moistness, heaviness, amount of grease, amount of tack, quickness of drying, overall skin feel, and overall appearance. After a designated time, each sample is again evaluated, this time for coverage, evenness of coverage, shine, matte, skin moistness, heaviness, and overall appearance. </p><p id="p0057" num="0057"> It is understood that the present invention is not limited to the embodiments specifically disclosed and exemplified herein. Various modifications of the invention will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the appended claims. Moreover, each recited range includes all combinations and subcombinations of ranges, as well as specific numerals contained therein. Additionally, the disclosures of each patent, patent application, and publication cited or described in this document are hereby incorporated herein by reference, in their entireties. 
</p></description><claims mxw-id="PCLM45845777" ref-ucid="WO-2012145621-A1" lang="EN" load-source="patent-office"><claim-statement><!-- EPO <DP n="9"/>--> Claims </claim-statement><claim id="clm-0001" num="1"><claim-text> 1. A compound, including salts, of the Formula (I):</claim-text><claim-text> <img id="imgf000009_0001" he="41" wi="133" file="imgf000009_0001.tif" img-format="tif" img-content="drawing" orientation="portrait" inline="no"/> </claim-text><claim-text> (I) </claim-text><claim-text>wherein: </claim-text><claim-text> m is 1, 2, 3, 4, 5, or 6; </claim-text><claim-text> Ria, Rib, R<sub>2a</sub>, R<sub>2</sub>b, Rta, and R<sub>4</sub>b, are, independently at each occurrence, H, optionally substituted C1-C6 alkyl; and </claim-text><claim-text> R3a, R3b and R5 are, independently, optionally substituted C1-C6 alkyl. </claim-text></claim><claim id="clm-0002" num="2"><claim-text>2. The compound of Claim 1, wherein m is 2, 3, or 4. </claim-text></claim><claim id="clm-0003" num="3"><claim-text>3. The compound of Claim 1, wherein at least one Rt<sub>a</sub> is C¾. </claim-text></claim><claim id="clm-0004" num="4"><claim-text>4. The compound of Claim 1 , wherein Rt<sub>a</sub> is -CH<sub>2</sub>OH. </claim-text></claim><claim id="clm-0005" num="5"><claim-text>5. The compound of Claim 1, wherein R<sub>¾</sub> is -CH<sub>2</sub>C]¾. </claim-text></claim><claim id="clm-0006" num="6"><claim-text>6. The compound of Claim 1, wherein Rj<sub>a</sub> and Rt<sub>b</sub> cooperate to form a cyclohexyl group. </claim-text></claim><claim id="clm-0007" num="7"><claim-text>7. The compound of Claim 1, wherein R5 is -CH<sub>2</sub>CH<sub>2</sub>OH. <!-- EPO <DP n="10"/>--> </claim-text></claim><claim id="clm-0008" num="8"><claim-text>8 The compound of Claim 1, wherein R]<sub>a</sub> and are each H. </claim-text></claim><claim id="clm-0009" num="9"><claim-text>9. The compound of Claim 1 , wherein R<sub>2a</sub> and R<sub>2</sub>b are each H. </claim-text></claim><claim id="clm-0010" num="10"><claim-text>10. The compound of Claim 1, wherein R3<sub>a</sub> and R3 are the same. </claim-text></claim><claim id="clm-0011" num="11"><claim-text>11. The compound of Claim 10, wherein R3<sub>a</sub> and R3 are each -C¾. </claim-text></claim><claim id="clm-0012" num="12"><claim-text>12. The compound of Claim 10, wherein R3<sub>a</sub> and R3 are each -CH<sub>2</sub>C]¾. </claim-text></claim><claim id="clm-0013" num="13"><claim-text>13. The compound of Claim 10, wherein R3<sub>a</sub> and R3b are each -CH<sub>2</sub>CH<sub>2</sub>OH. </claim-text></claim><claim id="clm-0014" num="14"><claim-text>14. The compound of Claim 1, wherein R<sub>3a</sub> and R<sub>3b</sub> are not the same. </claim-text></claim><claim id="clm-0015" num="15"><claim-text>15. The compound of Claim 14, wherein R3<sub>a</sub> is -CH<sub>2</sub>CH<sub>2</sub>OH. </claim-text></claim><claim id="clm-0016" num="16"><claim-text>16. The compound of Claim 15, wherein R3b is -(CH<sub>2</sub>)3C]¾. </claim-text></claim><claim id="clm-0017" num="17"><claim-text>17. A method for providing humectancy in a personal care composition, comprising including the compound of claim 1 into the personal care composition. </claim-text></claim><claim id="clm-0018" num="18"><claim-text>18. A hair care composition containing the compound of claim 1. </claim-text></claim><claim id="clm-0019" num="19"><claim-text>19. A skin care composition containing the compound of claim 1. </claim-text></claim></claims><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
